Chimeric Newcastle Disease Virus Protects Chickens against Avian Influenza in the Presence of Maternally Derived NDV Immunity

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Steglich, Constanze ^a   Grund, Christian ^a   Ramp, Kristina ^a   Breithaupt, Angele ^a   Höper, Dirk ^a   Keil, Günther ^a   Veits, Jutta ^a   Ziller, Mario ^a   Granzow, Harald ^a   Mettenleiter, Thomas C ^a   Römer Oberdörfer, Angela ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; CHNDVFHN PMV8H5 VACCINE; GLYCOPROTEIN; HYBRID PROTEIN; MATERNAL ANTIBODY; NEWCASTLE DISEASE PARAMYXOVIRUS PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS SIALIDASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; AVIAN PARAMYXOVIRUS TYPE 8; AVULAVIRUS; CHICKEN; CHIMERA; CONTROLLED STUDY; EGG; EXPRESSION VECTOR; F GENE; GENE EXPRESSION; GENE INSERTION; HN GENE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H5N1); MOLECULAR CLONING; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; VACCINE PRODUCTION; VIRAL GENETICS; VIRION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CHICKENS; IMMUNITY; INFLUENZA IN BIRDS; NEWCASTLE DISEASE VIRUS; VIRAL VACCINES;

EID: 84883369792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072530     Document Type: Article

References (47)

1. OIE website. Available: http://www.oie.int/fileadmin/Home/eng/Animal_Health_in_the_World/docs/pdf/graph_avian_influenza/graphs_HPAI_26_05_2013.pdf. Accessed 2013 May 26.
2. WHO website. Available: http://www.who.int/influenza/human_animal_interface/EN_GIP_20130604CumulativeNumberH5N1cases.pdf. Accessed 2013 June 4.
3. CFSPH website. Available: http://www.cfsph.iastate.edu/Vaccines/diseaselist/.php?disease=avian-influenza&lang=en. Accessed 2013 June 4.
4. Qiao CL, Yu KZ, Jiang YP, Jia YQ, Tian GB, et al. (2003) Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol 32(1):: 25-32. doi:10.1080/0307945021000070688. PubMed: 12745375.
5. Pavlova SP, Veits J, Mettenleiter TC, Fuchs W, (2009) Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine. 27(37):: 5085-5090. doi:10.1016/j.vaccine.2009.06.048. PubMed: 19573638.
6. Gao H, Cui H, Cui X, Shi X, Zhao Y, et al. (2011) Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site. PLOS ONE. 6(7):: e22549. doi:10.1371/journal.pone.0022549. PubMed: 21818336.
7. Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, et al. (2006) Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A 103(21):: 8197-8202. doi:10.1073/pnas.0602461103. PubMed: 16717197.
8. Ge J, Deng G, Wen Z, Tian G, Wang Y, et al. (2007) Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81(1):: 150-158. doi:10.1128/JVI.01514-06. PubMed: 17050610.
9. Ge J, Tian G, Zeng X, Jiang Y, Chen H, et al. (2010) Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine. Avian Dis. 54 (1 Suppl): 294-296. doi:10.1637/8731-032509-ResNote.1. PubMed: 20521648.
10. DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, et al. (2010) Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84(3):: 1489-1503. doi:10.1128/JVI.01946-09. PubMed: 19923177.
11. Römer-Oberdörfer A, Mundt E, Mebatsion T, Buchholz UJ, Mettenleiter TC, (1999) Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80(Pt 11):: 2987-2995. PubMed: 10580061.
12. Park MS, Steel J, García-Sastre A, Swayne D, Palese P, (2006) Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A 103(21):: 8203-8208. doi:10.1073/pnas.0602566103. PubMed: 16717196.
13. Schröer D, Veits J, Grund C, Dauber M, Keil G, et al. (2009) Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus. Avian Dis. 53: 190-197. doi:10.1637/8416-072308-Reg.1. PubMed: 19630223.
14. Chen H, (2009) Avian influenza vaccination: the experience in China. Rev Sci Tech 28(1):: 267-274. PubMed: 19618631.
15. Swayne DE, Pavade G, Hamilton K, Vallat B, Miyagishima K, (2011) Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Rev Sci Tech 30(3):: 839-870. PubMed: 22435196.
16. Sarfati-Mizrahi D, Lozano-Dubernard B, Soto-Priante E, Castro-Peralta F, Flores-Castro R, et al. (2010) Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels. Avian Dis. 54 (1 Suppl) 239-241. doi:10.1637/8735-032509-Reg.1. PubMed: 20521638.
17. International Committee on Taxonomy of Viruses (2012) In: King AMQ et al. (editors) Virus Taxonomy, Paramyxoviruses. Elsevier Academic Press San Diego, London. 672-685 pp.
18. Miller PJ, Afonso CL, Spackman E, Scott MA, Pedersen JC, et al. (2010) Evidence for a new avian paramyxovirus serotype 10 detected in Rockhopper penguins from the Falkland islands. J Virol 84(21):: 11496-11504. doi:10.1128/JVI.00822-10. PubMed: 20702635.
19. Briand FX, Henry A, Massin P, Jestin V, (2012) Complete genome sequence of a novel avian paramyxovirus. J Virol 86(14):: 7710. doi:10.1128/JVI.00946-12. PubMed: 22733876.
20. Terregino C, Aldous EW, Heidari A, Fuller CM, De Nardi R, et al. (2013) Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12). Arch Virol: pp. 2013 May 25. [Epub ahead of print] doi:10.1007/s00703-013-1735-2. PubMed: 23708253.
21. Samuel AS, Paldurai A, Kumar S, Collins PL, Samal SK, (2010) Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome. PLOS ONE. 5(2):: e9269. doi:10.1371/journal.pone.0009269. PubMed: 20174645.
22. Calain P, Roux L, (1993) The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 67(8):: 4822-4830. PubMed: 8392616.
23. Peeters BP, Gruijthuijsen YK, de Leeuw OS, Gielkens AL, (2000) Genome replication of Newcastle disease virus: involvement of the rule- of-six. Arch Virol 145(9):: 1829-1845. doi:10.1007/s007050070059. PubMed: 11043944.
24. Roberts A, Buonocore L, Price R, Forman J, Rose JK, (1999) Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol 73(5):: 3723-3732. PubMed: 10196265.
25. Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Möller P, et al. (2004) Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 78(10):: 5458-5465. doi:10.1128/JVI.78.10.5458-5465.2004. PubMed: 15113924.
26. Muik A, Kneiske I, Werbizki M, Wilflingseder D, Giroglou T, et al. (2011) Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J Virol 85(11):: 5679-5684. doi:10.1128/JVI.02511-10. PubMed: 21450833.
27. Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ, (2000) A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc Natl Acad Sci U S A 97(26):: 14680-14685. doi:10.1073/pnas.011510698. PubMed: 11114165.
28. Kim SH, Subbiah M, Samuel AS, Collins PL, Samal SK, (2011) Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses. J Virol 85(17):: 8582-8596. doi:10.1128/JVI.00652-11. PubMed: 21680512.
29. Peeters BP, de Leeuw OS, Verstegen I, Koch G, Gielkens AL, (2001) Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine. 19(13-14):: 1616-1627. doi:10.1016/S0264-410X(00)00419-9. PubMed: 11166884.
30. Nayak B, Dias FM, Kumar S, Paldurai A, Collins PL, et al. (2012) Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). Vaccine. 30(12):: 2220-2227. doi:10.1016/j.vaccine.2011.12.090. PubMed: 22222870.
31. Samuel AS, Subbiah M, Shive H, Collins PL, Samal SK, (2011) Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9. Vet Res. 42(1):: 38. doi:10.1186/1297-9716-42-38. PubMed: 21345199.
32. Buchholz UJ, Finke S, Conzelmann KK, (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73(1):: 251-259. PubMed: 9847328.
33. Ramp K, Topfstedt E, Wäckerlin R, Höper D, Ziller M, et al. (2012) Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination. Avian Dis. 56(1):: 208-217. doi:10.1637/9870-080311-Reg.1. PubMed: 22545548.
34. Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC, (2008) Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine. 26(19):: 2307-2313. doi:10.1016/j.vaccine.2008.02.061. PubMed: 18395947.
35. Geiser M, Cèbe R, Drewello D, Schmitz R, (2001) Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. BioTechniques. 31(1):: 88-90, 11464525.
36. Ramp K, Veits J, Deckers D, Rudolf M, Grund C, et al. (2011) Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens. Avian Dis. 55(3):: 413-421. doi:10.1637/9652-011111-Reg.1. PubMed: 22017039.
37. Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W, (2009) Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine. 27(5):: 773-785. doi:10.1016/j.vaccine.2008.11.033. PubMed: 19041677.
38. Werner O, Römer-Oberdörfer A, Köllner B, Manvell RJ, Alexander DJ, (1999) Characterization of avian paramyxovirus type 1 strains isolated in Germany during 1992 to 1996. Avian Pathol 28(1):: 79-88. doi:10.1080/03079459995082. PubMed: 16147552.
39. Hanson RP, Brandly CA, (1955) Identification of vaccine strains of Newcastle disease virus. Science. 122(3160):: 156-157. PubMed: 14396376.
40. CEC (1992) Council Directive 92/66/EEC introducing Community measures for the control of Newcastle disease. Official Journal of the European Community. L260: 1-20.
41. Alexander DJ, (1998) Newcastle disease and other avian paramyxoviruses. A laboratory manual for the isolation and identification of avian pathogens. American Association of Avian Pathologists, Kennett Square. pp 156-163.
42. R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org/.
43. Breithaupt A, Kalthoff D, Dale J, Bairlein F, Beer M, et al. (2011) Neurotropism in blackcaps (Sylvia atricapilla) and red-billed queleas (Quelea quelea) after highly pathogenic avian influenza virus H5N1 infection. Vet Pathol 48(5):: 924-932. doi:10.1177/0300985810386467. PubMed: 20974871.
44. Ramp K, Skiba M, Karger A, Mettenleiter TC, Römer-Oberdörfer A, (2011) Influence of insertion site of the avian influenza virus haemagglutinin (HA) gene within the Newcastle disease virus genome on HA expression. J Gen Virol 92: 355-360. doi:10.1099/vir.0.027268-0. PubMed: 21068215.
45. Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A, et al. (1991) Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 65(7):: 3514-3520. PubMed: 2041078.
46. Bray M, Lai CJ, (1991) Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci U S A 88(22):: 10342-10346. doi:10.1073/pnas.88.22.10342. PubMed: 1682924.
47. Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, et al. (2012) Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice. PLOS ONE. 7(8):: e44447. doi:10.1371/journal.pone.0044447. PubMed: 22952980.